Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...

A five-year trial of the weight loss drug tirzepatide in Greater Manchester was announced last October ...

Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...

A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...

Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...

For adults with obesity treated with once-weekly tirzepatide, cardiometabolic risk factor improvements were positively ...

Preclinical study shows oral PL7737 agonist outperforms tirzepatide alone in rodent models, supporting Palatin’s plans for ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

Tirzepatide reduces breast tumor growth in obese mice while improving metabolic health, offering hope as a dual-action cancer ...

A new study found weight loss injections may help reduce the risk of dementia and stroke in people who are obese and have ...